Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides

References

• Fendrick AM, Monto AS, Nightengale B, et al. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 2003;163:487-94
   PubMed Web of Science ®Google Scholar
• Hueston WJ, Mainous III AG. Acute bronchitis. Am Fam Physician 1998;57:1270-6
   PubMed Web of Science ®Google Scholar
• File TM Jr, Hadley JA. Rational use of antibiotics to treat respiratory tract infections. Am J Manag Care 2002;8:713-27
   PubMed Web of Science ®Google Scholar
• Flaherty KR, Saint S, Fendrick AM, et al. The spectrum of acute bronchitis. Using baseline factors to guide empirical therapy. Postgrad Med 2001;109:39-47
   PubMed Web of Science ®Google Scholar
• Kolodziej H. Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo®. Phytomedicine 2007;14(Suppl VI):9-17
   PubMedGoogle Scholar
• Germer S, Hauer H, Erdelmeier C, et al. A detailed view on the constituents of EPs® 7630. Planta Med 2007;73:821
   Web of Science ®Google Scholar
• Kolodziej H, Kiderlen AF. In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs® 7630. Phytomedicine 2007;14(Suppl VI):18-26
   Google Scholar
• Thäle C, Kiderlen AF, Kolodziej H. Anti-infective mode of action of EPs® 7630 at the molecular level. Planta Med 2007;73:821
   Web of Science ®Google Scholar
• Beil W, Kilian P. EPs® 7630, an extract from Pelargonium sidoides roots inhibits adherence of Helicobacter pylori to gastric epithelial cells. Phytomedicine 2007;14(Suppl VI):5-8
   PubMedGoogle Scholar
• Kayser O, Kolodziej H. Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme. Planta Med 1997;63:508-10
   PubMed Web of Science ®Google Scholar
• Kayser O, Kolodziej H, Kiderlen AF. Immunomodulatory principles of Pelargonium sidoides. Phytother Res 2001;15:122-6
   PubMed Web of Science ®Google Scholar
• Kolodziej H, Kayser O, Radtke OA, et al. Pharmacological profile of extracts of Pelargonium sidoides and their constituents. Phytomedicine 2003;10(Suppl IV):18-24
   PubMedGoogle Scholar
• Conrad A, Hansmann C, Engels I, et al. Extract of Pelargonium sidoides (EPs® 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro. Phytomedicine 2007;14(Suppl VI):46-51
   PubMedGoogle Scholar
• Conrad A, Engels I, Frank U. Extract of Pelargonium sidoides (EPs® 7630) displays anti-infective properties by enhanced phagocytosis and differential modulation of host-bacteria interactions. Planta Med 2007;73:822
   Web of Science ®Google Scholar
• Neugebauer P, Mickenhagen A, Siefer O, et al. A new approach to pharmacological effects on ciliary beat frequency in cell cultures – exemplary measurements under Pelargonium sidoides extract (EPs 7630). Phytomedicine 2005;12:46-51
   PubMed Web of Science ®Google Scholar
• Conrad A, Jung I, Tioua D, et al. Extract of Pelargonium sidoides (EPs® 7630) inhibits the interactions of group A-streptococci and host epithelia in vitro. Phytomedicine 2007;14 (Suppl VI):52-9
   PubMedGoogle Scholar
• Nöldner M, Schötz K. Inhibition of lipopolysaccharide-induced sickness behavior by a dry extract from the roots of Pelargonium sidoides (EPs® 7630) in mice. Phytomedicine 2007;14(Suppl VI):27-31
   PubMedGoogle Scholar
• Koch E, Biber A. Treatment of rats with the Pelargonium sidoides extract EPs® 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin. Phytomedicine 2007;14(Suppl VI):40-5
   PubMedGoogle Scholar
• Chuchalin AG, Berman B, Lehmacher W. Treatment of acute bronchitis in adults with a Pelargonium sidoides preparation (EPs® 7630): a randomized, double-blind, placebo-controlled trial. Explore 2005;1:437-45
   Google Scholar
• Matthys H, Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study. Curr Med Res Opinion 2007;23:323-31
   PubMed Web of Science ®Google Scholar
• Bachert C, Schapowal A, Funk P, et al. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. Rhinology 2009;47:51-8
   PubMed Web of Science ®Google Scholar
• Schapowal A, Heger M. EPs® 7630 Lösung (Umckaloabo®) bei Sinusitis. Z Phytotherapie 2007;28:58-65
   Google Scholar
• Williamson HA Jr. A randomized, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract 1984;19:481-6
   PubMed Web of Science ®Google Scholar
• Macfarlane J, Holmes W, Gard P, et al. Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet. BMJ 2002;324:91-4
   PubMed Web of Science ®Google Scholar
• Bartholomew DJ. Ordered tests in the analysis of variance. Biometrika 1961;48:325-32
   Web of Science ®Google Scholar
• Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994;50:1029-41
   PubMed Web of Science ®Google Scholar
• Kieser M, Bauer P, Lehmacher W. Inference on multiple endpoints in clinical trials with adaptive interim analyses. Biom J 1999;41:261-77
   Web of Science ®Google Scholar
• Alberta Clinical Practice Guideline Working Group. Guideline for the management of acute bronchitis. Reviewed and revised, January 2008 [cited 2010 January 15]. Available from: URL:http://www.topalbertadoctors.org/informed_practice/clinical_practice_guidelines/complete%20set/Bronchitis/acute_bronchitis_guideline.pdf
   Google Scholar
• Gonzales R, Sande MA. Uncomplicated acute bronchitis. Ann Intern Med 2000;133:981-91
   PubMed Web of Science ®Google Scholar
• Pullar T, Kumar S, Tindall H, et al. Time to stop counting the tablets?. Clin Pharmacol Ther 1989;46:163-8
   Google Scholar